Teva Pharma (NYSE: TEVA) announced that it is commencing concurrent offerings totaling approximately $6.75 billion, consisting of approximately $3.375 billion ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE